All News

2021

June

Featured News / Jun 08, 2021

Ushering in the next wave of biosimilars by unlocking their potential

Read More

May

Media Release / May 18, 2021

Sandoz announces plans to further strengthen its antibiotics manufacturing setup in Europe

Read More
Media Release / May 17, 2021

US Supreme Court denies Sandoz petition to review biosimilar Erelzi® (etanercept-szzs) case

Read More
Featured News / May 05, 2021

Asthma: A global burden needing innovative treatment

This World Asthma Day, we are revisiting the commitment we have made to help make a difference for patients living with respiratory diseases.

Read More
Media Release / May 03, 2021

Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine

Read More

April

Media Release / Apr 27, 2021

Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed.

Read More
Featured News / Apr 06, 2021

Listening to the Patient Perspectives: Richard Saynor in conversation with Patient Advocacy leader Sonia Tropé part 2

Read More

March

Media Release / Mar 16, 2021

Sandoz in-licenses brand and authorized generic of respiratory medicine Proventil® HFA (albuterol sulfate) Inhalation Aerosol from Kindeva Drug Delivery, with immediate generic availability in US

Read More
Featured News / Mar 03, 2021

Listening to the Patient Perspectives: Richard Saynor in conversation with Patient Advocacy leader Salvo Leone Part 2

Read More
How Can We Make a Greater Impact to Improve Patients’ Lives?
Featured News / Mar 01, 2021

How Can We Make a Greater Impact to Improve Patients’ Lives?

Pierre Bourdage via LinkedIn

Read More